BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
86.81
-1.60 (-1.81%)
At close: Mar 24, 2026, 4:00 PM EDT
87.00
+0.19 (0.22%)
After-hours: Mar 24, 2026, 7:59 PM EDT
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
$431,614
Profits / Employee
-$170,862
Market Cap
21.82B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,807 | 1,035 | 15.28% |
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | 1,310 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| Moderna | 4,700 |
| Genmab | 2,973 |
| Incyte | 2,844 |
| Insmed | 1,664 |
| argenx SE | 1,599 |
| Ascendis Pharma | 1,189 |
| Revolution Medicines | 883 |
BNTX News
- 20 hours ago - BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer - GlobeNewsWire
- 14 days ago - BioNTech SE (BNTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls - Benzinga
- 14 days ago - BioNTech SE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 14 days ago - One simple reason why BioNTech stock is a raging buy on today's crash - Invezz
- 14 days ago - BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture - Benzinga
- 14 days ago - Scientists behind COVID-19 vaccine will depart BioNTech - Market Watch
- 14 days ago - BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. - Barrons